COSMOS Pharmaceutical Corporation
3349.T · JPX
5/31/2025 | 5/31/2024 | 5/31/2023 | 5/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | ¥30,978 | ¥30,978 | ¥24,454 | ¥23,797 |
| Dep. & Amort. | ¥22,229 | ¥22,229 | ¥19,924 | ¥17,368 |
| Deferred Tax | ¥0 | ¥0 | ¥0 | ¥0 |
| Stock-Based Comp. | ¥0 | ¥0 | ¥0 | ¥0 |
| Change in WC | -¥3,303 | -¥3,303 | ¥9,666 | ¥13,205 |
| Other Non-Cash | ¥2,563 | ¥2,563 | ¥1,131 | ¥64 |
| Operating Cash Flow | ¥52,467 | ¥52,467 | ¥55,175 | ¥54,434 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -¥53,326 | -¥53,326 | -¥55,810 | -¥46,636 |
| Net Acquisitions | ¥0 | ¥0 | ¥718 | ¥46 |
| Inv. Purchases | -¥558 | -¥558 | -¥523 | -¥500 |
| Inv. Sales/Matur. | ¥417 | ¥417 | ¥431 | ¥428 |
| Other Inv. Act. | -¥1,981 | -¥1,981 | -¥2,145 | -¥2,451 |
| Investing Cash Flow | -¥55,448 | -¥55,448 | -¥57,329 | -¥49,113 |
| Financing Activities | – | – | – | – |
| Debt Repay. | ¥12,680 | ¥12,680 | ¥13,187 | ¥6,514 |
| Stock Issued | ¥0 | ¥0 | ¥0 | ¥0 |
| Stock Repurch. | -¥2 | -¥2 | ¥0 | -¥2 |
| Dividends Paid | -¥4,959 | -¥4,959 | -¥4,659 | -¥3,266 |
| Other Fin. Act. | -¥2 | -¥2 | -¥1 | -¥1 |
| Financing Cash Flow | ¥7,717 | ¥7,717 | ¥8,527 | ¥3,245 |
| Forex Effect | ¥1 | ¥1 | ¥0 | -¥1 |
| Net Chg. in Cash | ¥4,737 | ¥4,737 | ¥6,373 | ¥8,566 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | ¥52,301 | ¥52,301 | ¥45,928 | ¥37,362 |
| End Cash | ¥57,038 | ¥57,038 | ¥52,301 | ¥45,928 |
| Free Cash Flow | -¥859 | -¥859 | -¥635 | ¥7,798 |